MAUDE MDR 9462807

MDR report key
9462807
Report number
8010047-2019-04293
Event key
0
Event type
3
Date received
2019-12-12
Adverse event
3
Product problem
0
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MR KAZUTAKA MATSUMOTO
Address
2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO 192-8 JA
Phone
426-426-4264
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1EVIS LUCERA SMALL INTESTINAL VIDEOSCOPESMALL INTESTINAL VIDEOSCOPEOLYMPUS MEDICAL SYSTEMS CORP.FDASIF-Q260R N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12019-12-1201. O

Event Narratives#

N

Patient 1

THE SUBJECT DEVICE WAS NOT BEEN RETURNED TO OLYMPUS MEDICAL SYSTEMS CORP (OMSC). OMSC COULD NOT REVIEW THE SERVICE AND MANUFACTURING RECORD BECAUSE THE SERIAL NUMBER WAS NOT PROVIDED FROM THE FACILITY. AS PART OF OUR INVESTIGATION, OMSC REVIEWED ALL OF THE COMPLAINTS FOR THE PERIOD, BUT THERE WAS NO RECORD ASSOCIATED WITH THE EVENT DESCRIBED IN THE ARTICLE. THE EXACT CAUSE OF THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED.

D

Patient 1

OLYMPUS MEDICAL SYSTEMS CORP. (OMSC) WAS RECEIVED JDDW (JAPAN DIGESTIVE DISEASE WEEK) LITERATURE ABSTRACT THAT STATED THE RESULT OF THE ENDOSCOPIC TREATMENT FOR BILE DUCT STONES USING WITH SBE-ERCP (ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY USING WITH SINGLE BALLOON ENDOSCOPE) AND ULTRASOUND ENDOSCOPE TO THE PATIENTS WHOM HAD EXPERIENCED INTESTINAL RECONSTRUCTIVE SURGERY. THE LITERATURE ABSTRACT REPORTED THE RESULT OF THE ERCP PROCEDURES FOR BILE DUCT STONES IN 117 CASES FROM APRIL 2011 TO MARCH 2019. AS ACCIDENTAL SYMPTOMS, THE PANCREATITIS OCCURRED IN 5 CASES AFTER THE ERCP PROCEDURES, THE SMALL PERFORATION OCCURRED IN 1 CASE DURING THE PRE-CUT. THE EACH PATIENTS WERE TREATED CONSERVATIVELY. THE INTESTINAL PERFORATION OCCURRED IN 2 CASES AND IT REQUIRED THE OPEN ABDOMINAL SURGERY. BASED ON THE AVAILABLE INFORMATION, A DIRECT RELATIONSHIP BETWEEN THE OLYMPUS PRODUCT AND THE OBSERVED ADVERSE EVENTS COULD NOT BE DETERMINED. OMSC IS SUBMITTING MDR ACCORDING TO THE NUMBER OF TYPES OF THE ACCIDENTAL SYMPTOM. THIS IS 4 OF 8 REPORTS. (4 OF 5 PANCREATITIS CASES).